Osteoporosis: Weekly 28.2ug teriparatide reduces vertebral fracture risk
Once-Weekly Injection of Low-Dose Teriparatide (28.2 ug) Reduced the Risk of Vertebral Fracture in Patients with Primary OsteoporosisCalcif Tissue Int. 2014 Feb;94(2):170-5. doi: 10.1007/s00223-013-9777-8. Epub 2013 Aug 21
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
316 primary osteoporosis patients were randomized to receive a 28.2ug injection of teriparatide or placebo injection (1.4ug teriparatide) once-weekly for 3 years, to determine the effects of teriparatide on vertebral fracture prevention and lumbar spine BMD. Results indicated that teriparatide reduced the risk of vertebral fractures and increased lumbar bone mineral density compared to placebo, bu...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE